Dr. Naftali Kaminski, MD

Pulmonary Disease New Haven, CT Male
NPI: 1376918870
Total Payments
$195,450
2024 Payments
$525.00
Companies
9
Transactions
78

Payment Breakdown by Category

Consulting$184,793 (94.5%)
Travel$3,767 (1.9%)
Research$3,640 (1.9%)
Food & Beverage$2,310 (1.2%)
Other$940.00 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $184,793 24 94.5%
Travel and Lodging $3,767 19 1.9%
Unspecified $3,640 1 1.9%
Food and Beverage $2,310 33 1.2%
Honoraria $940.00 1 0.5%

Payments by Type

General
$191,810
77 transactions
Research
$3,640
1 transactions

Top Paying Companies

Company Total Records Latest Year
Boehringer Ingelheim Pharmaceuticals, Inc. $151,675 40 $0 (2023)
Merck Sharp & Dohme LLC $18,115 23 $0 (2024)
AstraZeneca UK Limited $8,850 4 $0 (2022)
Theravance Biopharma, Inc. $5,282 5 $0 (2018)
GlaxoSmithKline, LLC. $4,642 2 $0 (2023)
Biogen, Inc. $3,640 1 $0 (2018)
AstraZeneca AB $2,250 1 $0 (2023)
CSL Behring $940.00 1 $0 (2021)
Celgene Corporation $56.00 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $525.00 1 Merck Sharp & Dohme LLC ($525.00)
2023 $28,349 26 Merck Sharp & Dohme LLC ($17,590)
2022 $11,108 3 Boehringer Ingelheim Pharmaceuticals, Inc. ($9,608)
2021 $111,689 7 Boehringer Ingelheim Pharmaceuticals, Inc. ($106,924)
2020 $12,790 4 Boehringer Ingelheim Pharmaceuticals, Inc. ($9,265)
2019 $14,850 19 Boehringer Ingelheim Pharmaceuticals, Inc. ($14,794)
2018 $8,922 6 Theravance Biopharma, Inc. ($5,282)
2017 $7,219 12 Boehringer Ingelheim Pharmaceuticals, Inc. ($7,126)

All Payment Transactions

78 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
01/03/2024 Merck Sharp & Dohme LLC — Consulting Fee Cash or cash equivalent $525.00 General
Category: IMMUNOLOGY
10/31/2023 Boehringer Ingelheim Pharmaceuticals, Inc. — Consulting Fee Cash or cash equivalent $3,906.25 General
10/02/2023 Merck Sharp & Dohme LLC — Consulting Fee Cash or cash equivalent $9,450.00 General
10/02/2023 Merck Sharp & Dohme LLC — Consulting Fee Cash or cash equivalent $5,775.00 General
10/02/2023 Merck Sharp & Dohme LLC — Travel and Lodging Cash or cash equivalent $150.00 General
10/02/2023 Merck Sharp & Dohme LLC — Travel and Lodging Cash or cash equivalent $150.00 General
09/22/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $64.99 General
09/22/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $55.00 General
09/22/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $30.00 General
09/21/2023 Merck Sharp & Dohme LLC — Travel and Lodging In-kind items and services $349.00 General
09/21/2023 Merck Sharp & Dohme LLC — Travel and Lodging In-kind items and services $171.78 General
09/21/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $150.00 General
09/21/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $64.99 General
09/21/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $59.99 General
09/21/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $55.00 General
09/20/2023 Merck Sharp & Dohme LLC — Travel and Lodging In-kind items and services $171.78 General
09/20/2023 Merck Sharp & Dohme LLC — Travel and Lodging In-kind items and services $153.33 General
09/20/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $150.07 General
09/18/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $64.97 General
09/18/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $59.57 General
09/18/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $51.85 General
09/17/2023 Merck Sharp & Dohme LLC — Travel and Lodging In-kind items and services $249.00 General
09/17/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $133.90 General
09/17/2023 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $29.79 General
08/18/2023 AstraZeneca AB — Consulting Fee Cash or cash equivalent $2,250.00 General
1234»

Research Studies & Clinical Trials

Study Name Company Amount Records
Evaluating the Efficacy and Safety of BG00011 in Participants With Idiopathic Pulmonary Fibrosis Biogen, Inc. $3,640 1

About Dr. Naftali Kaminski, MD

Dr. Naftali Kaminski, MD is a Pulmonary Disease healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/09/2015. The National Provider Identifier (NPI) number assigned to this provider is 1376918870.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Naftali Kaminski, MD has received a total of $195,450 in payments from pharmaceutical and medical device companies, with $525.00 received in 2024. These payments were reported across 78 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($184,793).

Practice Information

  • Specialty Pulmonary Disease
  • Location New Haven, CT
  • Active Since 12/09/2015
  • Last Updated 12/09/2015
  • Taxonomy Code 207RP1001X
  • Entity Type Individual
  • NPI Number 1376918870

Products in Payments

  • OFEV (Drug) $5,494

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pulmonary Disease Doctors in New Haven

Michael Imevbore, M.d, M.D

Pulmonary Disease — Payments: $271,586

Pulmonary Disease $271,586

Lauren Cohn, Md, MD

Pulmonary Disease — Payments: $166,306

Pulmonary Disease $166,306

Wassim Fares, Md, Msc, MD, MSC

Pulmonary Disease — Payments: $128,283

Pulmonary Disease $128,283

Carrie Redlich, Md, MD

Pulmonary Disease — Payments: $8,441

Pulmonary Disease $8,441

Dr. Sushil Gupta, M.d, M.D

Pulmonary Disease — Payments: $5,175

Pulmonary Disease $5,175

Dr. Kaiser Toosy, Md, MD

Pulmonary Disease — Payments: $3,778

Pulmonary Disease $3,778